Page URL: https://www.bionews.org.uk/page_143203

Gene mutation in genome-edited babies linked to shorter life

10 June 2019
Appeared in BioNews 1001

The gene mutation that Dr He Jiankui aimed to emulate in the world's first genome-edited babies has been linked to increased risk of death in later life.

The birth of twin girls, genome-edited to be 'HIV-resistant' was announced by Dr He to a global outcry in November 2018. Dr He, then at the Southern University of Science and Technology in Shenzhen, and colleagues used CRISPR/Cas9 to delete a gene called CCR5 in the original embryos (see BioNews 977).

Dr He said his rationale for doing this was that a natural mutation in this gene has been shown to confer resistance to the HIV virus.

In response to the controversial experiment, Professor Rasmus Nielsen and Dr Xinzhu (April) Wei at the University of California, Berkeley, examined the genomes and related health records of over 400,000 people from the UK BioBank.

They found that people with two copies of the mutated CCR5 gene (known as CCR5-Delta32) had higher death rates between the ages of 41 to 78 compared with those with one copy or no copies of the mutant gene. They showed a 21 percent increase in mortality in later life.

'Beyond the many ethical issues involved with the CRISPR babies, the fact is that, right now, with current knowledge, it is still very dangerous to try to introduce mutations without knowing the full effect of what those mutations do,' said senior study author Professor Nielsen. 'In this case, it is probably not a mutation that most people would want to have. You are actually, on average, worse off having it.'

Study first author Dr Wei added: 'I think there are a lot of things that are unknown at the current stage about genes' functions. The CRISPR technology is far too dangerous to use right now for germline editing.'

One of the twin babies born from the genome-edited embryos has both copies of CCR5 deleted, while the other reportedly has one copy only deleted.

Professor Robin Lovell-Badge at the Francis Crick Institute in London, said it was 'impossible to predict if the mutations carried by the twin girls will have any effect'.

He added: 'All this shows once more that He Jiankui was foolish to choose CCR5 to mutate in his attempts at germline genome editing. We simply do not yet know enough about the gene.'

About 11 percent of northern Europeans carry the CCR5 gene mutation which confers resistance against HIV. The mutation has been linked to better recovery from stroke (see BioNews 988).

Professor Lovell-Badge suggested that 'it is likely that mutations in the gene also have bad effects'. But because the new study only looks at overall mortality – rather than causes – it does not yield any clues as to why people with two mutated CCR5 genes appear to have shorter lives.

'Human beings have CCR5 genes for a reason, even if we do not yet know the fully details about its functionality,' said Professor David Curtis, honorary professor at University College London's Genetics Institute.

'This sends us a warning that we should be extremely cautious around the introduction of therapies involving modifying the genetic code, since we can expect that there will be unexpected consequences.'

The study was published in Nature Medicine.

SOURCES & REFERENCES
A Mutation That Resists HIV Has Other Harmful Consequences
The Atlantic |  3 June 2019
CCR5-∆32 is deleterious in the homozygous state in humans
Nature Medicine |  3 June 2019
CRISPR baby mutation significantly increases mortality
Science Daily |  3 June 2019
He Jiankui: Baby gene experiment 'foolish and dangerous'
BBC |  3 June 2019
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
21 October 2019 - by Dr Barbara Kramarz 
There are numerous reasons why the story of two baby girls, who had been genetically engineered as embryos and consequently equipped with an HIV protective gene variant, startled researchers and the public around the world...
16 September 2019 - by Charlotte Spicer 
Chinese scientists have used the genome editing tool CRISPR in an attempt to treat HIV in a patient with blood cancer, for the first time...
9 September 2019 - by Dr Yvonne Collins 
A new genome-wide association study has identified specific gene regions that can influence left-handedness and differences in brain organisation which may be linked to better verbal skills...
17 June 2019 - by Helen Robertson 
A Russian scientist has announced his intention to produce genome-edited babies...
3 June 2019 - by Georgia Everett 
An international commission has been assembled to provide guidance on the development of therapies using human germline genome editing...
25 February 2019 - by Isobel Steer 
A gene called CCR5 has been shown to affect people's ability to recover after stroke. It is the same gene at the heart of the recent controversial case of genome edited babies in China...
3 December 2018 - by Rachel Siden 
Authorities in China are moving to suspend the research activities of the scientists who claim to have modified the genomes of twin girls with CRISPR-Cas9...
26 November 2018 - by Shaoni Bhattacharya 
The first births from genome-edited human embryos have been announced by a Chinese researcher amid widespread condemnation, and fears over safety...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.